Publication | Closed Access

The effect of halogenation on blood–brain barrier permeability of a novel peptide drug☆

Cerebral Vascular RegulationBlood–brain BarrierBlood–brain Barrier PermeabilityMedicinePeptide TherapeuticNeuropharmacologyPeptide ScienceNeuroprotectionNeurologyCerebral Blood FlowNovel Peptide Drug☆PharmacologyNeuropeptides